BioCentury
ARTICLE | Financial News

Idenix proposes direct public offering

February 3, 2014 8:00 AM UTC

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Cambridge, Mass. Business: Infectious Date announced: 1/28/14 Type: Direct public offering To be raised: $106.7 million Shares: 16.4 million Price: $6.50 Sha...